ADVFN Logo

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

ABBV AbbVie Inc

182,10
1,75 (0,97%)
Nach Börsenschluss
Zuletzt aktualisiert: 00:05:37
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
AbbVie Inc ABBV NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
1,75 0,97% 182,10 00:05:37
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
181,00 180,30 182,30 182,10 180,35
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
26.3.202412:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
25.3.202416:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25.3.202413:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25.3.202413:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
22.3.202420:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21.3.202413:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
07.3.202414:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
06.3.202414:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
05.3.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202418:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
05.3.202414:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
05.3.202413:00PRNUSDragonfly has Received Milestone Payment Following Dosing of..
02.3.202401:53EDGAR2Form 144 - Report of proposed sale of securities
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:20EDGAR2Form 144 - Report of proposed sale of securities
01.3.202400:06EDGAR2Form 144 - Report of proposed sale of securities
29.2.202423:33EDGAR2Form 144 - Report of proposed sale of securities
29.2.202422:04EDGAR2Form 144 - Report of proposed sale of securities
28.2.202406:05PRNUSAbbVie and OSE Immunotherapeutics Announce Partnership to..
27.2.202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202414:00GLOBEHealis Therapeutics' asset CKDB-501A shares Phase III..
27.2.202413:45PRNUSU.S. Food and Drug Administration (FDA) Grants Priority..
26.2.202423:08EDGAR2Form 8-K - Current report
26.2.202412:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:04EDGAR2Form 144 - Report of proposed sale of securities
22.2.202414:05PRNUSAbbVie and Tentarix Announce Collaboration to Develop..
22.2.202400:00EDGAR2Form 144 - Report of proposed sale of securities
21.2.202414:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21.2.202414:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024..
20.2.202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202415:00EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock